Lenovo to Be Main Sponsor of Red Bull Illume Image Quest 2021
25.2.2021 17:00:00 EET | Business Wire | Press release
The world’s greatest adventure and action sports imagery contest, Red Bull Illume® returns in 2021 with global technology leader, Lenovo™, as its Exclusive Computing Sponsor. A showcase for the best of adventure and action sports imagery, the competition is expected once again to receive tens of thousands of entries from around the world including some of the most creative and extreme images ever captured. As part of this two-year partnership, Lenovo will be involved through brand, product placement and logo incorporation for both online and in-person content, prizes for finalists and winners, as well as having promotional access to the incredible contest imagery.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210225005071/en/
Austrian photographer Philip Platzer gets the perfect in-air shot of Red Bull Skydive teammate, Marco Fürst, participating in The Megaswing Project. (Photo: Philip Platzer/ Red Bull Illume)
Lenovo enables a more inclusive and inspired world for all through smarter technology, so it’s fitting Lenovo should present this year’s Best of Instagram category that opens up the competition to all. Unlike the contest’s nine other categories which are adjudicated by a panel of 50 photo and digital experts from around the world, the finalists and category winners for Best of Instagram by Lenovo are selected through public voting. Each month, from March 1 to July 31, 2021, there will be five still and five moving images pre-selected by an internal jury which are put out to a community vote. The top choices from each month will become official Red Bull Illume Image Quest 2021 Finalists; from these, a final online vote will decide the best still image and the best moving image, to be crowned as Lenovo’s Best of Instagram Category Winners. Anyone can submit their moving or still images on Instagram by tagging @redbullillume and #rbi21submission.
The Overall Winner of Red Bull Illume Image Quest 2021 is selected from all the category winners by the international judging panel. There is a total of 10 categories which are created to truly shine a light on the lifestyle and culture behind today’s professional and amateur content creators and their dedication to the craft. Each edition of the contest brings out a new level of never-seen-before creativity, and this edition is bound to be full of imagery that pushes the boundaries of content creation in adventure and action sports imagery.
Along with receiving well-earned career exposure as an official Red Bull Illume winner, their work will tour the globe, illuminated on huge lightboxes. The winners are also awarded prize packages that include trophies and the latest Lenovo products to power even more creative self-expression. Their work will be included in the official Red Bull Illume photobook and showcased during the winner award ceremony planned for November 2021 and attended by Ulrich Grill, the founder of the Red Bull Illume Image Quest.
“Lenovo is proud to support the sixth edition of Red Bull Illume Image Quest that brings together photographers and content creators whose bold work continually inspires us,” said Matt Bereda, Vice President of Global Consumer Marketing, PCs and Smart Devices, Lenovo. “We see many of our consumer PC, smart home, and tablet customers are passionate hobbyists. They enjoy photography and digital storytelling, and not all of them are paid professionals—they just love capturing and enhancing imagery to share with others and hang on their walls. If this new normal has taught us anything about our world and ourselves, it’s that we’re resilient, our technology is adaptable, and that making meaningful connections with others through shared creative pursuits are the bright spots in life that really matter.”
“Red Bull Illume is like the Oscars of adventure and action sports imagery and we are extremely proud to have Lenovo join the 2021 edition,” said Ulrich Grill, Founder of Red Bull Illume. “This contest honors the creativity and hard work that goes into producing one-of-a-kind imagery and Lenovo gives content creators the tools they need to express their unique ideas.”
A shared dedication to transformative experiences and using innovative technology to push boundaries makes Red Bull Illume and Lenovo ideal partners. Meaningful innovation is essential to advancing photo technologies and solidifying image capture as an artform. Similarly, Lenovo innovation provides digital creators with better photo management and enhancement experiences and smarter technology so they can build bigger for a more creative world – making consumer products, services, and software solutions more attuned to the unique needs of modern content creators.
The contest is open for submissions from March 1 to July 31, 2021. It is free for anyone to enter and voting is open to all on redbullillume.com. To view previous winning images, check out the gallery, here.
About Lenovo
Lenovo (HKSE: 992) (ADR: LNVGY) is a US$50 billion Fortune Global 500 company, with 63,000 employees and operating in 180 markets around the world. Focused on a bold vision to deliver smarter technology for all, we are developing world-changing technologies that create a more inclusive, trustworthy and sustainable digital society. By designing, engineering and building the world’s most complete portfolio of smart devices and infrastructure, we are also leading an Intelligent Transformation – to create better experiences and opportunities for millions of customers around the world. To find out more visit https://www.lenovo.com, follow us on LinkedIn, Facebook, Twitter, YouTube, Instagram, Weibo and read about the latest news via our StoryHub.
About Red Bull Illume
The Image Quest 2021 is the sixth edition bringing together the amazing work of photographers and content creators from around the world. In 2019, a record-breaking 59,551 images were submitted by thousands of creators from countries all around the world. Submissions for the contest will take place from March 1 to July 31, 2021 and can be entered on redbullillume.com and on Instagram. A judging panel of 50 photo editors and digital experts will select the Finalists, Category Winners and an Overall Winner, to be unveiled at the Winner Award Ceremony in November 2021. Follow us on Instagram, Facebook, Twitter, YouTube and Pinterest.
LENOVO is a trademark of Lenovo. RED BULL ILLUME is a trademark of Red Bull GmbH. Instagram is a trademark of Instagram, LLC. All other trademarks are the property of their respective owners. ©2021, Lenovo Group Limited.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210225005071/en/
Contact information
Wendy Fung
wfung@zenogroup.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OPEX® Corporation Introduces the Velo™ Series of Premium Desktop and High Production Document Scanners10.2.2026 11:00:00 EET | Press release
OPEX® Corporation, a global leader in Next Generation Automation providing innovative solutions for warehouse, document and mail automation, has announced the launch of its Velo™ Series powered by InoTec, a new class of premium desktop and free standing high production scanners. The OPEX Velo scanners are engineered to deliver exceptional performance, reliability and image quality and offer industry-standard TWAIN/ISIS connectivity to help simplify deployment into existing capture environments. These state-of-the-art scanners are ideal for service bureaus, government agencies, healthcare providers and enterprise capture operations. “The Velo Series powered by InoTec introduces an entirely new class of scanners to the OPEX portfolio, expanding the options available to both our current customers and organizations considering OPEX for the first time,” said Dann Worrell, President, Document and Mail Automation, OPEX. “By broadening our offerings, we can better align the right solution with
New ZOLL Zenix Monitor/Defibrillator Receives MDR Approval10.2.2026 11:00:00 EET | Press release
ZOLL®, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that Zenix®, the company’s most clinically advanced and easy-to-use professional monitor/defibrillator, is approved under the European Union (EU) Medical Device Regulation 2017/745, commonly referred to as EU MDR. The Zenix monitor/defibrillator is a groundbreaking device that redefines efficiency, clarity, and intelligence in both EMS and hospital settings. Built from years of feedback from customers, Zenix combines intuitive design with powerful functionality to enhance patient care and automate workflows for ease-of-use. Featuring a large, durable touchscreen, Zenix provides critical information when it’s needed. With on-the-fly customization, healthcare professionals can make real-time adjustments, helping them stay in control during high-pressure situations. Equipped with ZOLL’s innovative Real BVM Help® and exclusive Real CPR Help® technology, Zenix gives healthcare pro
IEO and Laife Reply Join Forces to Digitalise the Biobank Through Artificial Intelligence10.2.2026 11:00:00 EET | Press release
The Pathology Division of the European Institute of Oncology (IEO) and Laife Reply, the Reply Group company specialised in AI and Big Data solutions for the healthcare sector, have entered into a collaboration to develop Bianca, the first project in Italy aimed at creating an AI-based digital biobank designed as an integral part of clinical diagnostic practice. The initiative is part of a broader technological innovation journey that structurally integrates research and development into routine diagnostic processes in pathology, transforming the traditional histopathological sample workflow into an end-to-end digital ecosystem. The complete digitalisation of histopathological and molecular diagnostic workflows aims to make analysis more efficient, scalable and reproducible, laying the foundations for the evolution of AI-supported oncological diagnostics. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210610418/en/ On this
Expereo Elevates expereoOne with New Digital Case Management Capabilities, Delivering Faster, Clearer and More Predictable Service Resolution10.2.2026 11:00:00 EET | Press release
Expereo is redefining what’s possible for global enterprises at CiscoLive Amsterdam with the launch of its enhanced Digital Case Management (DCM) capability in expereoOne. As the world-leading managed Network as a Service (NaaS) provider, Expereo is putting customers firmly in control - slashing resolution times, cutting through operational noise and ensuring everyone is aligned every step of the way. With DCM, service issues are no longer bottlenecks: instead, enterprises experience swift, transparent outcomes, with every stakeholder empowered through a single, real-time view of progress. DCM is designed around a simple objective: enable enterprises to resolve issues faster, with greater clarity and full control, through a fully digital, software-first workflow inside expereoOne. Customers can create, manage and track cases end-to-end within a single platform, ensuring predictable, consistent and aligned service experiences across their global network footprint. Unified, digital-first
U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 110.2.2026 10:15:00 EET | Press release
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) accepted its New Drug Application (NDA) and granted Priority Review for oveporexton (TAK-861) for the treatment of narcolepsy type 1 (NT1). Oveporexton is an investigational oral orexin receptor 2 (OX2R)-selective agonist designed to address the underlying orexin deficiency that causes NT1 by restoring orexin signaling. The FDA has set a Prescription Drug User Fee Act (PDUFA) goal date in the third quarter of this calendar year. Takeda remains on track to potentially bring the first approved orexin agonist treatment to people living with NT1. NT1 is a chronic, rare neurological disease caused by a loss of orexin and characterized by excessive daytime sleepiness and cataplexy (sudden loss of muscle tone). This results in a spectrum of physical, cognitive and psychosocial effects that can have a debilitating impact on many aspects of a person’s life, including work, education and social interactio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom